https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-23 14:14:482022-05-06 14:22:05Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson-Gilford Progeria.
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-23 14:08:342022-01-03 09:58:45Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-22 09:15:102022-01-03 09:58:59Lonafarnib: First Approval